Condition
Neuromuscular; Disorder, Hereditary
Total Trials
2
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Aiguided Patient Classification
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Enrolling By Invitation1
Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Aiguided Patient Classification1
Active Sponsors
- University of Modena and Reggio Emilia1
- Boston Children's Hospital1
- National Institute of Neurological Disorders and Stroke (NINDS)1
Top Investigators
University of Modena and Reggio Emilia
Boston Children's Hospital/Harvard Medical School
Related Conditions
- Duchennebecker Muscular Dystrophy1
- Limbgirdle Muscular Dystrophy1